希斯脱乙酶抑制剂恩诺斯通过EGFR信号通路和MDM2-p53轴发挥抗NSCLC作用
Sinian He1, Aoxuan Zhang1, Chaoyang Sui1
1Department of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, 330004, P.R. China.
Current pharmaceutical biotechnology
|January 8, 2026
概括
恩丁诺斯塔特通过减少表皮生长因子受体 (EGFR) 信号传递,有效地对抗非小细胞肺癌 (NSCLC). 在临床前模型中,这种基因组脱乙酶抑制剂 (HDACi) 显示出强大的抗瘤作用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 非小细胞肺癌 (NSCLC) 是一种高度攻击性的恶性瘤.
- 基因组脱乙酶抑制剂 (HDACi) 通过向信号通路,显示出在癌症治疗中的潜力.
- 表皮生长因子受体 (EGFR) 信号传导与NSCLC进展有关.
研究的目的:
- 评估HDAC抑制剂恩丁诺斯塔特对NSCLC的疗效.
- 调查恩丁诺斯塔特抗癌作用背后的机制.
- 评估Entinostat对EGFR信号通路的影响.
主要方法:
- 用MTT测定来评估细胞增殖.
- 西部斑点分析用于测量EGFR表达和下游信号.
- 细胞亡和瘤生长在体外和体内使用NSCLC细胞系和异种移植模型进行了评估.
主要成果:
- 与其他HDAC抑制剂相比,恩丁诺斯塔特表现出优异的抗NSCLC活性.
- 氨酸抑制了EGFR表达,并抑制了下游的信号通路 (STAT3,AKT,p38).
- 在体内研究显示,恩丁诺斯塔特显著抑制了瘤生长.
结论:
- 恩丁诺斯塔特表现出强大的抗NSCLC活性.
- 该机制涉及抑制EGFR表达和下游信号.
- 恩丁诺斯塔特是NSCLC治疗的有前途的治疗候选药物.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
The JAK-STAT Signaling Pathway
11.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.9K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.4K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.4K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K


